ANNA-2: An antibody associated with paraneoplastic opsoclonus in a patient with large-cell carcinoma of the lung with neuroendocrine features - Correlation of clinical improvement with tumor response

Cancer Investigation

Volumn 22, Issue 2, 2004, Pages 257-261

  Erlich, Rodrigo ^a   Morrison, Candis ^b   Kim, Bong ^b   Gilbert, Mark R ^c   Alrajab, Saadah ^d  

^a JOHNS HOPKINS BAYVIEW MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c UNIVERSITY OF TEXAS   (United States)

^d GREATER BALTIMORE MEDICAL CENTER   (United States)

Author keywords

Antibody; Large cell carcinoma; Paraneoplastic opsoclonus; Tumor response

Indexed keywords

ANTIBODY; CARBOPLATIN; ETOPOSIDE; RI ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ANTIBODY TITER; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CASE REPORT; CLINICAL FEATURE; FEMALE; HUMAN; HUMAN TISSUE; LARGE CELL CARCINOMA; LUNG CARCINOMA; MYOCLONUS; NEUROENDOCRINE TUMOR; NEUROLOGIC DISEASE; OPSOCLONUS; PARANEOPLASTIC OPSOCLONUS; PARANEOPLASTIC SYNDROME; PRIORITY JOURNAL;

ANTIBODIES, NEOPLASM; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG NEOPLASMS; MIDDLE AGED; PARANEOPLASTIC SYNDROMES, NERVOUS SYSTEM; PROGNOSIS; TREATMENT OUTCOME;

EID: 2642518066     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.1081/CNV-120030214     Document Type: Article

References (10)

1. Luque, A.F.; Furneaux, H.M.; Ferziger, R.; et al. Anti-Ri: an antibody associated with paraneoplastic opsoclonus and breast cancer. Ann. Neurol. 1991, 29, 241-251.
2. Furneaux, H.M.; Reich, L.; Posner, J.B. Autoantibody synthesis in the central nervous system of patients with paraneoplastic syndromes. Neurology 1990, 40, 1085-1091.
3. Darnell, R.B.; Posner, J.B. Cloning and characterization of the neuronal antigen recognized in paraneoplastic opsoclonus-myoclonus. Neurology 1990, 41 (Suppl 1), 363.
4. Posner, J.B. Paraneoplastic cerebellar degeneration. Principle and practice of oncology. PPO Updat. 1991, 5 (11), 1-13.
5. Anderson, N.E.; Budde-Steffen, C.; Rosenblum, M.K.; et al. Opsoclonus, myoclonus, ataxia, and encephalopathy in adults with cancer: a distinct paraneoplastic syndrome. Medicine 1988, 67, 100-109.
6. Ross, A.J.; Zeman, W. Opsoclonus occult carcinoma and chemical pathology in dentate nuclei. Arch. Neurol. 1967, 17, 546-551.
7. Ridley, A.; Kennard, C.; Scholtz, C.L.; et al. Omnipause neurons in two cases of opsoclonus associated with oat cell carcinoma of the lung. Brain 1987, 110, 1699-1709.
8. Dropcho, E.; Payne, R. Paraneoplastic Opsoclonus-myoclonus. Association with medullary thyroid carcinoma and review of the literature. Arch. Neurol. (Chic.) 1986, 43, 410-415.
9. Nausieda, P.A.; Tanner, C.M.; Weiner, W.J. Opsoclonus cerebellopathy: a paraneoplastic syndrome responsive to thiamine. Arch. Neurol. (Chic.) 1981, 38, 780-781.
10. Leigh, R.J.; Zee, D.S. The diagnostic value of abnormal eye movements: a pathological approach. Johns Hopkins Med. J. 1982, 151, 122-135.